Latent tuberculosis: revised treatment guidelines.

about

The risk of tuberculosis transmission in solid organ transplantation: Is it more than a theoretical concern?

P2860

Q36171107-9509E2F6-D936-4635-A78B-C600F945AA1C

P2860

Latent tuberculosis: revised treatment guidelines.

Item

http://www.wikidata.org/entity/Q39982606

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Latent tuberculosis: revised treatment guidelines.

@en

Latent tuberculosis: revised treatment guidelines.

@nl

type

Item

label

Latent tuberculosis: revised treatment guidelines.

@en

Latent tuberculosis: revised treatment guidelines.

@nl

prefLabel

Latent tuberculosis: revised treatment guidelines.

@en

Latent tuberculosis: revised treatment guidelines.

@nl

P1476

Latent tuberculosis: revised treatment guidelines

@en

P2093

David N Fisman

http://www.w3.org/2001/XMLSchema#string

Erica Weir

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.

Tuberculosis: 9. Treatment.

Outcomes of contact investigations of infectious tuberculosis patients.

Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact

Tuberculosis: 12. Global disease and the role of international collaboration

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

Prospects for vaccines to protect against AIDS, tuberculosis, and malaria.

Latent tuberculosis treatment.

P304

937-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14581314

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

219630

http://www.w3.org/2001/XMLSchema#string

Latent tuberculosis: revised treatment guidelines.

about

P2860

P2860

Latent tuberculosis: revised treatment guidelines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932